Qiagen N.V. Stock News

Investors are optimistic about QIAGEN (QGEN) on strong third-quarter results and raised 2021 guidance.

The global Gene Panel market is expected to reach US$ 7.8 Billion by 2027, with a CAGR of 19.7% from 2021 to 2027. Over the forecast period, the increased prevalence of chronic diseases linked to genes, such as stroke, heart

Investors are optimistic about QIAGEN (QGEN) on strong third-quarter results and raised 2021 guidance.

QIAGEN's (QGEN) QuantiFERON SARS-CoV-2 assay enables a comprehensive assessment of immunity developed by COVID-19 vaccines.

QIAGEN's (QGEN) QuantiFERON SARS-CoV-2 assay enables a comprehensive assessment of immunity developed by COVID-19 vaccines.

Equities research analysts expect that QIAGEN (NYSE:QGEN) will announce earnings of $0.60 per share for the current quarter, Zacks reports. Three analysts have issued estimates for QIAGENs earnings. The lowest EPS estimate is $0.60 and the highest is $0.61. QIAGEN posted earnings per share of $0.68 in the same quarter last year, which would suggest []

Qiagen (QGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Poultry Diagnostics Market report makes available an overview of the industry which is gaining momentum in the last few years. The market report uses a range of steps for collecting, recording, analysing and interpreting market data to make this report

Overview of Global Human Leukocyte Antigen (HLA) Typing for Transplant Market: Human Leukocyte Antigen (HLA) Typing for Transplant is a professional and wide-ranging report containing market parameters about the Healthcare industry. The report pinpoints on the leading Market competitors with explaining

Major liquid biopsy market players include BIOCEPT, Inc., QIAGEN, Myriad Genetics, Inc., Lucence health Inc., Guardant Health, Inc. and F. Hoffmann-La Roche. Major liquid biopsy market players include BIOCEPT, Inc., QIAGEN, Myriad Genetics, Inc., Lucence health Inc., Guardant Health, Inc. and F. Hoffmann-La Roche.

Protein purification and isolation market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 11.21 billion by 2027, growing at a CAGR of 8.35%

By Ana Mano SAO PAULO, Nov 30 (Reuters) Brazilian food processor BRF BRFS3.SA wants to persuade the Qatar Investment Authority (QIA) to remain a partner in TBQ Foods and maintain their 40% stake in the company, according to a BRF executive. In a brief telephone interview on Tuesday, BRF Chief Financial Officer Carlos Moura [] The post Brazils BRF wants to keep Qatar group as partner in TBQ Foods -CFO appeared first on UK Stocks, Forex, Commodities, Crypto, Live Market News- Daily Forex News .

QIAGEN (QGEN) and DiaSorin gained FDA approval for their jointly-created LIAISON QuantiFERON-TB Gold Plus assay for use on DiaSorin's automated LIAISON XS platform.

Brazilian meat giant BRF is negotiating with Qatar Investment Authority (QIA), its joint venture partner in the ownership of Turkey-based Read More... The post BRF seeking to take full control of Turkey-based poultry processor Banvit appeared first on Just Food .

QIAGEN (QGEN) and DiaSorin gained FDA approval for their jointly-created LIAISON QuantiFERON-TB Gold Plus assay for use on DiaSorin's automated LIAISON XS platform.